Dr La was most recently vice president of pharmacogenetics experimental project coordination and analysis, at GlaxoSmithKline.
Dr Lai has earned a PhD in pharmacology and microbiology from Columbia University, MPhil and MA degrees from the department of pharmacology at Columbia, and a BS in chemistry from the University of Waterloo in Ontario, Canada.
Carl Hull, president and COO of Gen-Probe, said: “We are very pleased to add Eric’s scientific expertise and leadership to our already strong senior management team. We believe Eric will play an integral role in helping our R&D team drive short-, medium- and long-term product sales growth for the company.”